Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
about
Cutaneous manifestations of hepatitis C in the era of new antiviral agentsPrimary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health PerspectivePruritus in Systemic Diseases: A Review of Etiological Factors and New Treatment ModalitiesPrimary biliary cirrhosis: Clinical and laboratory criteria for its diagnosisJaundice associated pruritis: a review of pathophysiology and treatmentBile acid signaling in metabolic disease and drug therapyNeural processing of itch.Clinical application of transcriptional activators of bile salt transporters.Recent advances in the management of pruritus in chronic liver diseasesFibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.Not all (bile acids) who wander are lost: the first report of a patient with an isolated NTCP defectManagement of pruritus in chronic liver disease.Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang.Potentiation of the transient receptor potential vanilloid 1 channel contributes to pruritogenesis in a rat model of liver disease.Nuclear receptors as drug targets in cholestatic liver diseases.Proposed therapies in primary biliary cholangitis.Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases.Pruritus: an overview. What drives people to scratch an itch?Refractory pruritus in primary biliary cirrhosisNatural history and management of primary biliary cirrhosis.Hits of a high-throughput screen identify the hydrophobic pocket of autotaxin/lysophospholipase D as an inhibitory surface.Diagnosis and Management of Chronic Pruritus: An Expert Consensus Review.Bile acids reach out to the spinal cord: new insights to the pathogenesis of itch and analgesia in cholestatic liver diseaseBile acid transporters and regulatory nuclear receptors in the liver and beyondBile acid receptors as targets for drug development.Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis.Primary biliary cirrhosis in adults.Pruritus in cholestasis: facts and fiction.Novel therapeutic targets in primary biliary cirrhosis.Chronic pruritus in the elderly: pathophysiology, diagnosis and management.Primary sclerosing cholangitis: a clinical update.A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis.Advances in therapeutic strategies for the treatment of pruritus.Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease.The impact of intensified hemodialysis on pruritus in an end stage renal disease patient with biliary ductopenia.Treatment of pruritus with Prometheus dialysis and absorption system in a patient with benign recurrent intrahepatic cholestasis.Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study.Prevalence and Relevance of Pruritus in Pregnancy.Complications, symptoms, quality of life and pregnancy in cholestatic liver disease.[Intrahepatic cholestasis of pregnancy : Rare but important].
P2860
Q26773669-FB063AB7-D91D-4092-9C60-879EE1F68520Q26781780-4FACF164-553F-4DBE-8651-2891A843943DQ26799175-97076D9F-BBB0-4472-B0AA-999490ACCFB4Q26992087-49A92AF5-3E32-4C81-9565-E39953F25FAAQ28084371-1146D3AC-2E13-48F1-B554-9CDE2E6AB46FQ28244875-849C891C-B98A-4736-9127-5F1474A1F6F5Q30428749-A5ADC8F9-7A86-4825-AB32-C62CE42F7931Q33709930-82BB1FFF-FFFF-4751-811B-7D171DFFDF0CQ33719935-FBA9776B-1104-47E1-B68E-AA6DAB7FF2DEQ33721771-540CD888-A527-40E1-B0C8-F637FFDA2C8CQ34791055-F077CE81-E2C8-4757-B089-A2DCEB449706Q35226847-8CE1E96B-7AEB-4B73-AA16-8E9A276088C1Q35607454-02179E3E-D5EC-4A2A-B4A5-13A47AED3B23Q36742184-959F5F99-CFBD-4B5E-ACA1-BB601F6061D3Q36786270-A9AFC03D-9014-4082-8411-0C0EEB3193C9Q37072380-7895C853-2EB6-4DD7-B811-75491596D816Q37163154-E767AEC5-F57E-4452-996A-EB24CD029ED2Q37272308-61985609-50C8-4457-BBB6-EC4AE9C45EBDQ37314381-52C6245D-E897-4F66-A6D7-D5B494ABDFECQ37355843-E40D1CE9-3A84-4155-8064-0E16A3FDBC8EQ37422766-D22E8696-9177-41A8-A439-35FFCD33993AQ37618589-A016A9C5-CB67-49DA-88B8-74D36D8BD7A0Q37666088-0533993C-62E0-4326-BD8D-486B51FBF028Q38033967-81F0CE3D-0EAC-481F-B95C-8AD599D9F821Q38132058-385E086D-CB02-4510-A9CF-8C695686D045Q38175055-487D69D2-C034-4B58-AED6-25BB1FFC7839Q38192045-B918DE91-EEEE-40D3-8CF7-093EB2438D0CQ38210112-CF1F1D3D-9D7D-4DF2-B870-75D272E44FD5Q38342107-CE87702E-791C-479F-9922-14E6B518D5CDQ38360710-7796AEC6-209A-4C14-9085-E46AA01CCECCQ38485235-F755DB49-BF7F-4823-9DEA-2E05FB76C6E4Q38637490-C41CC0AA-C3C2-4F31-9374-E1784498479CQ38656850-311D5E45-4E16-4FD9-9BAD-27255469A307Q39116967-85306126-56C8-40AF-98E7-8ACA1F1BEF02Q41908724-C3B2DA1E-E1C8-414B-BC7A-65918C4D4E3FQ44832218-8E76FAE7-88ED-4BDE-8177-4AD12849611EQ46111528-A3ABFC5B-F8BB-49EB-A48E-9F0E2EFF4174Q47154799-5CEF63F6-E487-4F17-8F87-2108E45DBA30Q48331749-5198C801-4093-44A6-8C4D-CE35CE19A04CQ51273998-501ED850-C917-4B4C-AFA2-C24C150C43F8
P2860
Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Serum autotaxin is increased i ...... to therapeutic interventions.
@en
Serum autotaxin is increased i ...... to therapeutic interventions.
@nl
type
label
Serum autotaxin is increased i ...... to therapeutic interventions.
@en
Serum autotaxin is increased i ...... to therapeutic interventions.
@nl
prefLabel
Serum autotaxin is increased i ...... to therapeutic interventions.
@en
Serum autotaxin is increased i ...... to therapeutic interventions.
@nl
P2093
P2860
P356
P1433
P1476
Serum autotaxin is increased i ...... to therapeutic interventions.
@en
P2093
Andreas Engert
Christian Rust
Edith M M Kuiper
Henk R van Buuren
Karel J van Erpecum
Katrin S Reiners
Nathan A Davies
Pamela Leckie
Rajiv Jalan
Remco van Dijk
P2860
P304
P356
10.1002/HEP.25748
P407
P577
2012-10-01T00:00:00Z